Brock A Arivett
Overview
Explore the profile of Brock A Arivett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
692
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ohneck E, Arivett B, Fiester S, Wood C, Metz M, Simeone G, et al.
PLoS One
. 2018 Jan;
13(1):e0190599.
PMID: 29309434
The capacity of Acinetobacter baumannii to persist and cause infections depends on its interaction with abiotic and biotic surfaces, including those found on medical devices and host mucosal surfaces. However,...
12.
Kidane D, Arivett B, Crigler J, Vick E, Farone A, Farone M
Genome Announc
. 2017 May;
5(18).
PMID: 28473387
is a Gram-variable bacterium associated with bacterial vaginosis, a common vaginal inflammation in women of reproductive age. This study reports the whole-genome sequencing for the clinical isolate strain ATCC 49145....
13.
Rumbo-Feal S, Perez A, Ramelot T, Alvarez-Fraga L, Vallejo J, Beceiro A, et al.
Front Cell Infect Microbiol
. 2017 Apr;
7:108.
PMID: 28421168
Genetic and functional studies showed that some components of the ATCC 17978 A1S_0112-A1S_0119 gene cluster are critical for biofilm biogenesis and surface motility. Recently, our group has shown that the...
14.
Park H, Nelson D, Taylor Z, Hayes J, Cunningham K, Arivett B, et al.
Int Immunopharmacol
. 2016 Dec;
43:116-128.
PMID: 27988459
Suppressing cytokine responses has frequently been shown to have promising therapeutic effects for many chronic inflammatory and autoimmune diseases. However, the severe side effects associated with the long-term use of...
15.
Fiester S, Arivett B, Schmidt R, Beckett A, Ticak T, Carrier M, et al.
PLoS One
. 2016 Nov;
11(11):e0167068.
PMID: 27875572
Acinetobacter baumannii is an opportunistic Gram-negative pathogen that causes a wide range of infections including pneumonia, septicemia, necrotizing fasciitis and severe wound and urinary tract infections. Analysis of A. baumannii...
16.
Arivett B, Ream D, Fiester S, Kidane D, Actis L
Genome Announc
. 2016 Aug;
4(4).
PMID: 27563036
Acinetobacter baumannii is a Gram-negative bacterium capable of causing hospital-acquired infections that has been grouped with Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species as...
17.
Arivett B, Ream D, Fiester S, Kidane D, Actis L
Genome Announc
. 2016 Aug;
4(4).
PMID: 27516516
Pseudomonas aeruginosa, a Gram-negative bacterium that causes severe hospital-acquired infections, is grouped as an ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) pathogen because...
18.
Arivett B, Ream D, Fiester S, Kidane D, Actis L
Genome Announc
. 2016 Aug;
4(4).
PMID: 27516515
Members of the Escherichia coli bacterial family have been grouped as ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) pathogens because of their extensive...
19.
Mehari Y, Arivett B, Farone A, Gunderson J, Farone M
Genome Announc
. 2016 Feb;
4(1).
PMID: 26893424
"Candidatus Berkiella cookevillensis" and "Candidatus Berkiella aquae" are obligate intranuclear endosymbionts of freshwater amoebae. Here, we present the draft genome sequences of these two bacteria, with total sizes of 2,990,361...
20.
Arivett B, Fiester S, Ohneck E, Penwell W, Kaufman C, Relich R, et al.
Antimicrob Agents Chemother
. 2015 Sep;
59(12):7657-65.
PMID: 26416873
A paucity of effective, currently available antibiotics and a lull in antibiotic development pose significant challenges for treatment of patients with multidrug-resistant (MDR) Acinetobacter baumannii infections. Thus, novel therapeutic strategies...